Basic information
- CAS
61758-77-8- Standard SMILES
O=C(O)C(=O)O.[NH-]C1CCCCC1[NH-].[Pt+2]- InChIKey
DRMCATBEKSVAPL-UHFFFAOYSA-N- Molecular formula
- C8H14N2O4Pt
- Average molar mass
- 397.29 g/mol
- Monoisotopic mass
- 397.060151
Names & identifiers
- Preferred name
- Oxaliplatin (Eloxatin)
- IUPAC
- (2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+)
- English name
- Oxaliplatin impurity D
- Molecular formula
- C8H12N2O4Pt
- Molecular weight
- 395.26988
Names & synonyms
NCGC00167798-01NSC271670Oxaliplatin (Eloxatin)NSC266038NSC266042NSC 266042NSC-266038NSC-271670NCGC00167798-02NCGC00167798-04NCGC00167798-05Platinum,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2)-(cis))-
Show more names
(S,S)-Oxaliplatin[SP-4-2-(1S-trans)]-OXALIPLATIN IMPURITY DOxaliplatin Impurity 4Oxaliplatin-ImpurityD(EP/BP)S,S-enantiomer of oxaliplatinOxaliplatin Related CoMpound DOxaliplatin Related Compound D (10 mg)
Platinum,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(1S-trans))-Platinum,2-cyclohexanediamine-N,N')[ethanedioato(2-)-O,O']-, [SP-4-2-(cis)]-
Database identifiers
- CAS
61758-77-8- PubChem CID
- 4609
Properties
Computed structural properties
- Topological polar surface area
- 76.6 Ų
- Hydrogen bond donors
- 4
- Hydrogen bond acceptors
- 6
- Rotatable bonds
- 0
- Heavy atoms
- 15
- Formal charge
- 0
- Complexity
- 191
Physicochemical properties
- Melting point
- 210 °C · >210°C (dec.)
- storage temp.
- Refrigerator
- solubility
- DMSO (Slightly), Water (Slightly)
- form
- Solid
- color
- White
- Major Application
- pharmaceutical
- FDA UNII
- 9 R3J9FW · EDV9R3J9FW
- UNSPSC Code
- 41116107 · 41116107
- NACRES
- 24 · NA.24
- HS Code
- 2843900000 · 2843900000
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Safety data
- hs_code
- 2843900000
Chemistry & industry
Applications
UsesThe (S,S) Oxaliplatin isomer. Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.
Suppliers29 total
成都彼样生物科技有限公司18108052721 · [email protected]
杭州鼎燕化工有限公司13588754826 13588754826 · [email protected]
安耐吉化学&3A（安徽泽升科技有限公司）021-58432009 400-005-6266 · [email protected]
上海相辉医药科技有限公司13761987713; 13761987713 · [email protected]
贵州迪大科技有限责任公司0851-8475-2296 18096062265 · [email protected]
泰州市众致生物科技有限公司[email protected] 15066129350 · [email protected]
南京世洲生物科技有限公司13675144456 · [email protected]
深圳菲斯生物科技有限公司0755-83725350 13380397412 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
常州翔龙医药科技有限公司18915873328 18915873328 · [email protected]
上海双福生物科技有限公司+86-021-58380978 13482386415 · [email protected]
凯试（上海）科技有限公司021-50135380 · [email protected]
Related reactions
0 records
No reaction records under the current filter.
Compound notes
Loading…